These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1441 related items for PubMed ID: 24275954

  • 1. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG.
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [Abstract] [Full Text] [Related]

  • 2. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G, Muser D, Gianfagna P, Morocutti G, Proclemer A.
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [Abstract] [Full Text] [Related]

  • 3. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA.
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [Abstract] [Full Text] [Related]

  • 4. Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement.
    Spartera M, Damascelli A, Mozes F, De Cobelli F, La Canna G.
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1351-1360. PubMed ID: 28299606
    [Abstract] [Full Text] [Related]

  • 5. Impact of Global and Segmental Hypertrophy on Two-Dimensional Strain Derived from Three-Dimensional Echocardiography in Hypertrophic Cardiomyopathy: Comparison with Healthy Subjects.
    Voilliot D, Huttin O, Hammache N, Filippetti L, Vaugrenard T, Aliot E, Sadoul N, Juillière Y, Selton-Suty C.
    J Am Soc Echocardiogr; 2015 Sep; 28(9):1093-102. PubMed ID: 25935111
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X, Yue Y, Wang Y, Deng Y, Liu L, Di Y, Sun S, Chen D, Fan L, Cao J.
    Cardiovasc Ultrasound; 2018 Oct 02; 16(1):23. PubMed ID: 30285887
    [Abstract] [Full Text] [Related]

  • 8. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: The effects of myocardial hypertrophy and fibrosis.
    Xu HY, Chen J, Yang ZG, Li R, Shi K, Zhang Q, Liu X, Xie LJ, Jiang L, Guo YK.
    J Magn Reson Imaging; 2017 Nov 02; 46(5):1368-1376. PubMed ID: 28370909
    [Abstract] [Full Text] [Related]

  • 9. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.
    Rev Esp Cardiol; 2007 Jan 02; 60(1):15-23. PubMed ID: 17288951
    [Abstract] [Full Text] [Related]

  • 10. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK, Forero JF, Popovic ZB, Phelan D, Delgado D, Rakowski H, Wintersperger BJ, Thavendiranathan P.
    J Cardiovasc Magn Reson; 2017 Aug 07; 19(1):61. PubMed ID: 28784140
    [Abstract] [Full Text] [Related]

  • 11. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
    Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ.
    J Cardiovasc Magn Reson; 2012 Oct 29; 14(1):76. PubMed ID: 23107451
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
    Chang SA, Lee SC, Choe YH, Hahn HJ, Jang SY, Park SJ, Choi JO, Park SW, Oh JK.
    Int J Cardiovasc Imaging; 2012 Dec 29; 28 Suppl 2():133-40. PubMed ID: 23097128
    [Abstract] [Full Text] [Related]

  • 15. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S, Puchalski MD, Everitt MD, Williams RV, Weng HY, Menon SC.
    Pediatr Cardiol; 2016 Apr 29; 37(4):663-73. PubMed ID: 26833321
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R, Fernández-Golfín C, González-Gómez A, Rincón LM, Plaza-Martin M, Casas E, García-Martín A, Fernandez-Mendez MA, Esteban A, Nacher JJJ, Zamorano JL.
    Int J Cardiol; 2017 Dec 15; 249():467-472. PubMed ID: 29121751
    [Abstract] [Full Text] [Related]

  • 17. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT, Silva Vieira M, Kutty S, Lotz J, Hasenfu G, Chiribiri A, Schuster A.
    Invest Radiol; 2017 Mar 15; 52(3):177-185. PubMed ID: 27741021
    [Abstract] [Full Text] [Related]

  • 18. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T, Iwanaga Y, Yasuda M, Kawamura T, Miyaji Y, Morooka H, Miyazaki S.
    Int J Cardiovasc Imaging; 2016 Apr 15; 32(4):613-20. PubMed ID: 26589516
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM, Haugaa KH, Strøm EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T.
    Heart; 2014 Apr 15; 100(8):631-8. PubMed ID: 24368281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.